Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.82+0.34 (+22.97%)
Close on Nov 18, 2026Market cap $107.80MP/E –Yield –
Adagene revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $7.67M, up 7332.8% from the year before. The highest annual figure on record is $18.11M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.67M | +7332.8% |
| FY2024 | Dec 31, 2024 | $103.20K | -99.4% |
| FY2023 | Dec 31, 2023 | $18.11M | +94.9% |
| FY2022 | Dec 31, 2022 | $9.29M | -8.7% |
| FY2021 | Dec 31, 2021 | $10.18M | +1351.7% |
| FY2020 | Dec 31, 2020 | $700.91K | +46.0% |
| FY2019 | Dec 31, 2019 | $480.00K | -68.2% |
| FY2018 | Dec 31, 2018 | $1.51M | – |
See a number that looks wrong?